Fifty 1 Labs and UAV Corp to Host Virtual Shareholder Teleconference Featuring Nobel Laureate
July 28th, 2025 1:29 PM
By: Newsworthy Staff
Fifty 1 Labs and UAV Corp announce a virtual shareholder teleconference featuring Nobel Laureate Dr. James Orbinski, highlighting strategic initiatives in AI-driven health solutions and biotech investments.
Fifty 1 Labs, Inc. (OTC: FITY) and UAV Corp (OTC: UMAV) are set to host a virtual shareholder teleconference on July 28, 2025, featuring Nobel Laureate Dr. James Orbinski, to discuss the companies' strategic roadmap, including AI-driven drug repurposing and significant R&D investments. The event, emphasizing Fifty 1 AI Labs' advancements in functional medicine and plans for a biotech acquisition by 2027, underscores the companies' commitment to innovation and shareholder alignment. CEO Paul Arora highlighted the potential for growth and global health impact through off-patent drug repurposing and adaptive trials. For more details, visit https://ibn.fm/vdzmf.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
